SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Diversicare Healthcare Services, Inc. – ‘10-Q’ for 6/30/16 – ‘EX-3.8’

On:  Thursday, 8/4/16, at 4:29pm ET   ·   For:  6/30/16   ·   Accession #:  1628280-16-18521   ·   File #:  1-12996

Previous ‘10-Q’:  ‘10-Q’ on 5/5/16 for 3/31/16   ·   Next:  ‘10-Q’ on 11/3/16 for 9/30/16   ·   Latest:  ‘10-Q’ on 11/9/21 for 9/30/21   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/16  Diversicare Healthcare Svcs, Inc. 10-Q        6/30/16   53:4.4M                                   Workiva Inc Wde… FA01/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        2016 Q2 10-Q                                        HTML    475K 
 2: EX-3.8      Articles of Incorporation/Organization or Bylaws    HTML     18K 
 3: EX-10.1     Material Contract                                   HTML     18K 
 4: EX-10.2     Material Contract                                   HTML     85K 
 5: EX-10.3     Material Contract                                   HTML     67K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 8: EX-32       Certification -- §906 - SOA'02                      HTML     21K 
15: R1          Document and Entity Information                     HTML     36K 
16: R2          Interim Consolidated Balance Sheets                 HTML    130K 
17: R3          Interim Consolidated Balance Sheets                 HTML     43K 
                (Parenthetical)                                                  
18: R4          Interim Consolidated Statements of Operations       HTML    108K 
19: R5          Interim Consolidated Statements of Operations       HTML     23K 
                (Unaudited) (Parenthetical)                                      
20: R6          Interim Consolidated Statements of Comprehensive    HTML     38K 
                Income (Loss)                                                    
21: R7          Interim Consolidated Statements of Cash Flows       HTML    134K 
22: R8          Business                                            HTML     23K 
23: R9          Consolidation and Basis of Presentation of          HTML     25K 
                Financial Statements                                             
24: R10         Recent Accounting Guidance                          HTML     31K 
25: R11         Long-Term Debt and Interest Rate Swap               HTML     33K 
26: R12         Commitments and Contingencies                       HTML     40K 
27: R13         Stock-Based Compensation                            HTML     94K 
28: R14         Earnings (Loss) Per Common Share                    HTML     74K 
29: R15         Equity Method Investment                            HTML     24K 
30: R16         Business Development and Other Significant          HTML     55K 
                Transactions                                                     
31: R17         Subsequent Event                                    HTML     21K 
32: R18         Consolidation and Basis of Presentation of          HTML     38K 
                Financial Statements (Policies)                                  
33: R19         Stock-Based Compensation (Tables)                   HTML     87K 
34: R20         Earnings (Loss) Per Common Share (Tables)           HTML     71K 
35: R21         Business Development and Other Significant          HTML     49K 
                Transactions(Tables)                                             
36: R22         Business (Narrative) (Details)                      HTML     33K 
37: R23         Consolidation and Basis of Presentation of          HTML     19K 
                Financial Statements (Narrative) (Details)                       
38: R24         Recent Accounting Guidance (Narrative) (Details)    HTML     20K 
39: R25         Long-Term Debt and Interest Rate Swap (Narrative)   HTML     87K 
                (Details)                                                        
40: R26         Commitments and Contingencies (Narrative)           HTML     65K 
                (Details)                                                        
41: R27         Stock-Based Compensation (Narrative) (Details)      HTML     60K 
42: R28         Share-Based Compensation (Share-based Compensation  HTML     42K 
                Arrangement by Share-based Payment Award, Awards,                
                Vested and Expected to Vest, Outstanding and                     
                Exercisable) (Details)                                           
43: R29         Stock-Based Compensation (Restricted Stock and      HTML     55K 
                Restricted Stock Units Activity) (Details)                       
44: R30         Stock-Based Compensation (Schedule of Awards        HTML     43K 
                Outstanding and Exercisable) (Details)                           
45: R31         Earnings (Loss) Per Common Share (Basic and         HTML     63K 
                Diluted Net Income (Loss) Per Common Share)                      
                (Details)                                                        
46: R32         Earnings (Loss) Per Common Share (Narrative)        HTML     21K 
                (Details)                                                        
47: R33         Equity Method Investment (Narrative) (Details)      HTML     27K 
48: R34         Business Development and Other Significant          HTML     52K 
                Transactions (Narrative) (Details)                               
49: R35         Business Development and Other Significant          HTML     54K 
                Transactions (Schedule of Assets Acquired)                       
                (Details)                                                        
50: R36         Subsequent Event (Details)                          HTML     26K 
52: XML         IDEA XML File -- Filing Summary                      XML     86K 
51: EXCEL       IDEA Workbook of Financial Reports                  XLSX     50K 
 9: EX-101.INS  XBRL Instance -- avca-20160630                       XML    877K 
11: EX-101.CAL  XBRL Calculations -- avca-20160630_cal               XML    170K 
12: EX-101.DEF  XBRL Definitions -- avca-20160630_def                XML    337K 
13: EX-101.LAB  XBRL Labels -- avca-20160630_lab                     XML   1.11M 
14: EX-101.PRE  XBRL Presentations -- avca-20160630_pre              XML    591K 
10: EX-101.SCH  XBRL Schema -- avca-20160630                         XSD    112K 
53: ZIP         XBRL Zipped Folder -- 0001628280-16-018521-xbrl      Zip    132K 


‘EX-3.8’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


CERTIFICATE OF AMENDMENT
OF CERTIFICATE OF INCORPORATION
OF
DIVERSICARE HEALTHCARE SERVICES, INC.
Diversicare Healthcare Services, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, (the “DGCL”), acting pursuant to Section 242 of the DGCL, does hereby certify that:
1.    The Certificate of Incorporation of the Corporation is hereby amended by deleting in its entirety Item 3. of Article NINTH thereof and inserting the following in lieu thereof:
“3.    Beginning with 2016 annual meeting of stockholders and at each annual meeting thereafter, the term of office of each director elected at the annual meeting of stockholders, or elected or appointed at any time in the period between annual meetings of stockholders, shall expire at the next annual meeting of stockholders following such election or appointment. Nothing in this Item 3 of ARTICLE NINTH shall shorten the term of any director elected before the 2016 annual meeting of stockholders. Each director elected or appointed shall serve until his or her successor is elected and qualified, or until his or her earlier death, resignation, removal, or disqualification.”
2.    The foregoing amendment to the Certificate of Incorporation of the Corporation has been duly adopted in accordance with Sections 242, 141(f) (by the directors of the Corporation), and 211 (at the annual meeting of the stockholders of the Corporation) of the DGCL.
IN WITNESS WHEREOF, this Certificate of Amendment has been executed by a duly authorized officer of the Corporation on this 9th day of June, 2016.

DIVERSICARE HEALTHCARE SERVICES, INC.

By:    /s/ Kelly J. Gill            
Name:    Kelly J. Gill
Title:    President and Chief Executive Officer


16723746.1



7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/09/21  Diversicare Healthcare Svcs, Inc. 10-Q        9/30/21   64:6.9M                                   Workiva Inc Wde… FA01/FA
 8/12/21  Diversicare Healthcare Svcs, Inc. S-8         8/12/21    4:132K
 8/10/21  Diversicare Healthcare Svcs, Inc. 10-Q        6/30/21   62:6.7M
 5/11/21  Diversicare Healthcare Svcs, Inc. 10-Q        3/31/21   64:6M
 3/11/21  Diversicare Healthcare Svcs, Inc. 10-K       12/31/20   82:9.5M
11/05/20  Diversicare Healthcare Svcs, Inc. 10-Q        9/30/20   66:11M
 8/06/20  Diversicare Healthcare Svcs, Inc. 10-Q        6/30/20   61:8.4M
Top
Filing Submission 0001628280-16-018521   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 5, 4:19:27.1am ET